Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Recruiting · NCT07067255 · Registry updated 2025-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian carcinoma, ovarian disorder, ovarian sarcoma | Recruiting | Phase 1 / Phase 2 | 2025-07-16 | NCT07067255 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Essen Biotech | 17 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| District One Hospital | Beijing | China | 17 |